Anzeige
Mehr »
Donnerstag, 11.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PVC2 | ISIN: KYG4783B1032 | Ticker-Symbol: 33C
Tradegate
08.09.25 | 11:42
1,990 Euro
+4,19 % +0,080
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
INNOCARE PHARMA LTD Chart 1 Jahr
5-Tage-Chart
INNOCARE PHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,7901,89016:03
1,8001,87016:04

Aktuelle News zur INNOCARE PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoInnoCare Pharma: Singapore Approves HIBRUKA For Treatment Of R/R Marginal Zone Lymphoma In Adults4
MoInnoCare Pharma: InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore51BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA...
► Artikel lesen
20.08.INNOCARE (09969): GRANT OF RESTRICTED SHARE UNITS PURSUANT TO 2023 SHARE AWARD SCHEME2
INNOCARE PHARMA Aktie jetzt für 0€ handeln
20.08.INNOCARE (09969): GRANT OF RESTRICTED SHARES PURSUANT TO 2024 RMB SHARE INCENTIVE SCHEME-
19.08.INNOCARE (09969): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 20252
18.08.DMS Group: An International Alliance For European Technological Sovereignty In Medical Imaging - Capital Increase Of A Total Amount Of Eur 6.9 Million Reserved For Innolux, Innocare, Bpifrance And NextStage AM410A major international industrial alliance, supported by major institutional investors. DMS Group, a fast-growing European industrial player, is joining forces with two listed Asian technology...
► Artikel lesen
05.08.INNOCARE (09969): DATE OF BOARD MEETING2
24.07.UBS raises InnoCare Pharma stock price target to HK$25.20 on pipeline potential3
24.07.UBS hebt Kursziel für InnoCare Pharma wegen Pipeline-Potenzial auf 25,20 HK$ an10
18.07.INNOCARE (09969): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARE CAPITAL2
20.06.INNOCARE (09969): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 20 JUNE 2025-
13.06.InnoCare Pharma: Data of InnoCare's Robust Hemato-Oncology Pipelines Presented at the European Hematology Association (EHA) 2025 Congress409Latest data of InnoCare's (HKEX: 09969; SSE: 688428) robust oncology pipelines were presented at the ongoing European Hematology Association (EHA) 2025 Congress. Poster Presentation: 1. First...
► Artikel lesen
21.05.INNOCARE (09969): INSIDE INFORMATION ANNOUNCEMENT - APPROVAL OF MINJUVI (TAFASITAMAB) IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF ADULT PATIENTS ...1
14.05.China's InnoCare Turns First Profit in First Quarter2
13.05.INNOCARE (09969): 2025 QUARTERLY REPORT FOR THE FIRST QUARTER-
13.05.InnoCare's Mesutoclax obtains breakthrough therapy designation in China3
05.05.Chinese regulator grants priority review for InnoCare's solid tumour treatment2
28.04.China approves InnoCare Pharma's BTK inhibitor for lymphoma2
28.04.INNOCARE (09969): DATE OF BOARD MEETING-
28.04.INNOCARE (09969): FORM OF PROXY FOR ANNUAL GENERAL MEETING-
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1